DS
ONCO icon

DRW Securities’s Onconetix ONCO Stock Holding History

DRW Securities’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-781
Closed -$60.9K – 1611
2025
Q4 		$60.9K Sell
781
-455
-37% -$62.6K ﹤0.01% 1104
2025
Q3 		$192K Buy
+1,236
New +$208K ﹤0.01% 1094

Other funds holding ONCO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

DRW Securities's ONCO Position: Q1 2026 in Review

DRW Securities sold out of Onconetix (ONCO) in Q1 2026, closing a stake of 781 shares — an estimated $60.9K sold.

DRW Securities first reported a position in ONCO in Q3 2025 and held it in 2 quarters. The position peaked at $192K in Q3 2025. 5 funds tracked by Wall St. Rank hold ONCO as of Q1 2026.

  • DRW Securities reported no remaining Onconetix position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 781 Onconetix shares in Q1 2026, an estimated $60.9K.
  • DRW Securities first reported a position in Onconetix in Q3 2025 and held it in 2 quarters.
  • DRW Securities's Onconetix position peaked at $192K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.